Literature DB >> 34084618

Somatosensory evoked potentials and Hirayama disease.

Adeel Shakil Zubair1, Brian Crum2.   

Abstract

Entities:  

Year:  2021        PMID: 34084618      PMCID: PMC8168644          DOI: 10.25259/SNI_88_2021

Source DB:  PubMed          Journal:  Surg Neurol Int        ISSN: 2152-7806


× No keyword cloud information.
Dear Sir, Hirayama disease (HD) is a rare sporadic condition which is defined by a slowly progressive, asymmetric distal amyotrophy in the upper limbs. This condition usually presents in the juvenile years and is often clinically detected by muscle weakness and atrophy in the arms. Patients can also endorse symptoms of cold paresis which is the aggravation of muscle weakness on exposure to the cold. While the etiology of HD is currently unclear, many theories exist. One theory is that there is forward displacement of the posterior wall of the lower cervical dural canal in neck flexion causing compression and flattening of the spinal cord. Given this, somatosensory evoked potentials (SSEPs) have been discussed as a potential electrophysiologic measure. A recent study by Fustes et al. presented a series of eight cases with HD for whom the SSEP test did not turn out to be an electrophysiologic marker.[1] We report a series of six patients who were diagnosed with HD between 2004 and 2012. The average age of our cohort at diagnosis was 32.8, with all six being males. These patients all underwent ulnar SSEP studies which were normal, providing additional data that the SSEP test may not be an electrophysiologic marker for patients with HD. Our studies were not done with patients in the flexed neck position. However, a study by Misra et al. found that there was no significant change in SSEPs and F-wave parameters in HD patients when their neck was flexed versus at baseline.[2] Other small studies have shown that there may be some difference in SSEPs when compared to controls.[3,4] The usual protocol for upper extremity SSEP is to use the median sensory nerve, which will not interrogate the lower cervical segment as well as the ulnar nerve SSEP. Further large studies are needed to determine the utility of SSEP in this patient population. Given the variance of data published, it is also possible that there are different phenotypes of the disease which may present differently, furthering the need for large studies. Sincerely, Adeel S. Zubair, MD Brian Crum, MD
  4 in total

1.  The reversible effect of neck flexion on the somatosensory evoked potentials in patients with Hirayama disease: a preliminary study.

Authors:  Jin-Sung Park; Jin Young Ko; Donghwi Park
Journal:  Neurol Sci       Date:  2018-10-24       Impact factor: 3.307

2.  A clinical, magnetic resonance imaging, and survival motor neuron gene deletion study of Hirayama disease.

Authors:  U K Misra; J Kalita; V N Mishra; A Kesari; B Mittal
Journal:  Arch Neurol       Date:  2005-01

3.  Cervical cord dysfunction during neck flexion in Hirayama's disease.

Authors:  D Restuccia; M Rubino; M Valeriani; M Mirabella; M Sabatelli; P Tonali
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

4.  Somatosensory evoked potentials in Hirayama disease: A Brazilian study.

Authors:  Otto Hernandez Fustes; Cláudia Suemi Kamoi Kay; Paulo José Lorenzoni; Renata Dal-Prá Ducci; Lineu Cesar Werneck; Rosana Herminia Scola
Journal:  Surg Neurol Int       Date:  2020-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.